We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Thomas
Blakeman
t.m.blakeman@manchester.ac.uk
Dr
Kelly
Howells
kelly.howells@manchester.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Renal failure
This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.
Kidneys are essential for our health. They have a number of vital roles. These include filtering our blood and getting rid of waste and excess water by converting it into urine.
“Acute Kidney Injury” (AKI) refers to a circumstance when the kidneys suddenly stop working properly within hours or a few days. There are many reasons why AKI can occur. The most common cause is when our body becomes short of salt and water, such as when people become dehydrated from diarrhoea and vomiting.
AKI affects 1 in 7 people admitted to hospital unexpectedly. One in 5 people will need to be admitted to hospital again as an emergency within a month and 1 in 3 within three months. If someone has had AKI they are also more likely to develop lasting kidney damage known as chronic kidney disease.
The planned study is funded by the NIHR Health Services & Delivery Research programme (NIHR131948) and through three work packages it aims to understand and improve care following hospital discharge for people affected by AKI:
WORK PACKAGE 1 entails quantitative analysis of anonymised patient data accessed through the Clinical Practice Research Datalink. We will analyse large numbers of medical records to assess the current care for people leaving hospital following AKI.
WORK PACKAGE 2 entails qualitative research. We will interview people to learn from their experiences of care following AKI. With people’s permission, we will interview others involved in their care, such as a family member, their GP, nurse, pharmacist or member of hospital staff.
WORK PACKAGE 3 entails qualitative research. We will hold participatory workshops with key stakeholders, where we will discuss findings from the interviews and medical records. Through qualitative analysis of data generated through shared learning, we aim to develop recommendations to improve the quality of post-discharge care.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Qualitative;
You can take part if:
You may not be able to take part if:
WORK PACKAGE 2 - Qualitative case studies: 1. People who do not fall within one of the two groups specified in A17-1. 2. People who are in receipt of palliative care 3. People who lack capacity to consent 4. Patients who have not been informed about their AKI 5. Patients whose healthcare team deem the research would add distress/burden or alternative wording Patients who research participation would not been deemed appropriate (judged by their Clinical Care Team as per ethical issues outlined in A6-2 and A22). WORK PACKAGE 3 - Qualitative participatory workshops with representation from patient and professional stakeholders: 1. People who lack capacity to consent
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Kelly
Howells
kelly.howells@manchester.ac.uk
Dr
Thomas
Blakeman
t.m.blakeman@manchester.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by University of Manchester and funded by NIHR Evaluation, Trials and Studies Co-ordinating Centre (NETSCC) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 53452
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
